AR and prostate neoplasm: AR are directly related to the onset and progression of prostate tumors in men, with several underlying mechanisms involved, especially in those patients with CRPC, including amplification or mutations in receptors, changes in androgen biosynthesis, and/or changes in the binding cofactor of AR, resulting in modification of its transcriptional activity [92].